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The effect of exposure to dexamethasone and serum-deprivation on myofibrillar protease activity was 
determined by following cleavage of [r4C]globin by isolated myofibrils obtained from rat skeletal muscle 
in culture. Dexamethasone [lo-‘M] produced a 46% increase in protease activity, and serum-deprivation 
caused a 50% increase in activity over that of the enzyme in control cultures. The increases in proteolysis 
occurred concurrently with increased rate of overall protein degradation in these cells and were not 
associated with changes in cell viability. In cultured rat cardiac muscle cells dexamethasone failed to 
enhance myofibrillar protease activity, while serum-deprivation produced a 52% increase in the enzyme 
activity, Addition of insulin (50 mu/ml) to the cultures did not affect proteolysis or myofibrillar protease 
activity, but completely prevented the dexamethasone-induced increase of these activities. This effect of 
insulin suggests that the increase of muscle proteolysis in insulin-deficient diabetic animals reflects an 
enhanced response of the muscle to circulating glucocorticoids rather than a direct effect of insulin- 
deprivation on muscle proteolysis. Taken together, the present observations indicate that muscle cells in 
culture retain the ability to respond to catabolic stimuli by adaptive changes in the myofibrillar protease 
activity in a manner analogous to that of their parent tissue in the intact animal. 
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1. INTRODUCTION 
Protein degradation in skeletal muscle is 
regulated by a variety of factors including the 
nutritional state of the animal [l], availability of 
certain amino acids [2], insulin [3,4] and glucocor- 
ticoid hormones [4,5]. However, the relative im- 
portance of specific proteolytic enzymes in the 
nutritionally- and hormonally-controlled pro- 
teolysis is as yet uncertain [a]. We had focused our 
attention on the myofibrillar alkaline protease of 
skeletal and cardiac muscle [7,8] particularly 
because this activity appeared to be associated with 
the contractile proteins that are degraded. We 
found that this activity is adaptive and correlates 
with concomitant changes in muscle proteolysis 
(e.g., it increased following starvation) in diabetes 
and after glucocorticoid hormone treatment 
[7-101. 
Using skeletal and cardiac muscle cells in culture 
we have attempted to establish whether the 
myofibril-bound alkaline protease is involved in 
the tissue-specific proteolytic response to glucocor- 
ticoids, serum-deprivation and insulin. 
2. MATERIALS AND METHODS 
Ham F-10 tissue culture medium, fetal bovine 
serum and horse serum were obtained from GIB- 
CO (Grand Island NY). L[U-14C]Phenylalanine in 
sterile, aqueous solution, 450 mCi/mmol, and 
Naz”CrO4 in sterile isotonic solution, 250-500 
mCi/mmol, were obtained from the Radio- 
chemical Centre (Amersham). L-Phenylalanine 
was purchased from Sigma (St Louis MO). Dexa- 
methasone (sodium phosphate) was obtained from 
Ikapharm (Tel Aviv) and insulin (Actrapid, 
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monocomponent, 40 III/ml) from Novo (Copen- 
hagen). 
Neonatal rats of the Hebrew University strain 
were used as the source of skeletal muscle and car- 
diac muscle primary culture cells. 
The procedure for isolation and culture of 
myoblast-enriched skeletal and cardiac muscle cells 
was described in [l 11, and the cells grown for 5 
days. These cultures were composed of over 90% 
functioning myoblasts and contained no mast cells 
by microscopical examination [111. In some experi- 
ments lo-’ M dexamethasone sodium phosphate 
was added to the medium on the first day of 
growth and at every change of medium. When in- 
dicated, insulin, 50 mu/ml, was added twice daily 
for 5 days to the culture. On the fifth day of 
culture the medium was removed, the cells washed 
3 times in medium containing the same amount of 
dexamethasone or insulin as during the growth 
period and incubated for an additional 48 h in the 
medium before harvesting. For the serum-depriva- 
tion experiments erum was omitted from the 48 h 
incubation medium. 
The procedure of labeling the cells with radioac- 
tive phenylalanine and determination of the rate of 
proteolysis by release of label in presence of excess 
(chase) concentrations of non-labeled phenyl- 
alanine was previously described in detail [lo]. 
Viability measured by ‘iCr retention was found to 
correlate with viability measured by the trypan 
blue dye exclusion method ([lo] and Chaouat and 
Mayer, unpublished). 
Myofibrillar protease activity of skeletal and 
cardiac muscle cells was assayed after the cells were 
grown in culture and incubated for 48 h with the 
various tested compounds as described above. The 
cells were harvested and washed 3 times in 
potassium phosphate buffer, 0.01 M (pH 7.7) con- 
taining 0.05 M KCl. For each determination 
12 x IO6 cells were used. The cells were disrupted 
by repeated freezing and thawing. The pellet was 
washed 3 times in the same buffer, the supernatant 
was discarded and the sediment containing the 
myofibrillar protease was resuspended in 1 ml of 
the buffer. Protease activity was determined accor- 
ding to [13] with the modification that i4C-labeled 
globin was used instead of hemoglobin. The 
specific activity of the globin substrate was usually 
around 3 x 10’ cpm/mg protein. The enzyme ac- 
tivity was expressed in pg globin degraded.mg 
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protein - ’ . h - ‘. Protein was determined according 
to [14] using bovine albumin as standard. In dif- 
ferent experiments different specific activities of 
the myofibrillar enzyme in control cells were 
noted. The cause of these fluctuations in enzyme 
activity is as yet undetermined. 
In all experiments statistical analysis was per- 
formed by Student’s t-test. 
3. RESULTS 
Table 1 shows that addition of dexamethasone 
to cultured myoblasts produced a significant in- 
crease in the specific activity of [14C]globin- 
degrading alkaline protease associated with the 
myofibrillar fraction of skeletal muscle cells. 
However, dexamethasone had no effect on the 
same enzyme in cardiac muscle cells. Table 1 also 
shows that deprivation of serum from the medium 
for 48 h caused an increase in the alkaline 
myofibrillar protease activity of both skeletal and 
cardiac muscle cells in culture. Viability as assessed 
by 51Cr retention was not affected under these 
conditions. 
The effect of insulin on proteolysis and 
myofibrillar protease activities in cultured 
Table 1 
Effect of dexamethasone and serum-deprivation  
myofibrillar protease activity of cultured skeletal and 
cardiac muscle cells 
Muscle 
cells 
Control Dexamethasone Serum 
deprivation 
Pg globin.mg protein- ‘.h - ’ 
Skeletal 
Cardiac 
125* 11 183 f lS* 189+ 17* 
126zt 13 124zt 12 192* lSa 
’ Significantly different from control value, p<O.Ol 
Myoblasts were obtained from either hind-thigh skeletal 
or cardiac muscle and grown in culture for 5 days in 
presence or absence of 10-l M dexamethasone. Subse- 
quently the cells were washed and incubated for 48 h in 
presence or absence of either 10 - ’ M dexamethasone or 
20% serum. Myofibrillar protease activity was determin- 
ed by rate of hydrolysis of [14C]globin by myofibrils ob- 
tamed from the cells after the incubation and is given in 
mean values -+SEM for 5 plates/group. Viability as 
assayed by retention of “Cr was between 87% and 91% 
in all experimental groups 
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Table 2 
Effect of dexamethasone and insulin on cultured myoblasts 
Addition Proteolysis Myofibrillar protease activity Viability 
(a) (ug globin.mg protein-‘.h-‘1’ _ (qo) 
None 29*2 123 f 17 86* 10 
Dexamethasone 53*6* 214 f 15’ 80* 3 
Insulin 27*3 123i 13 82* 6 
Dexamethasone + insulin 28*3 133 f lob 81* 3 
Cardiac muscle myoblasts 
None 35&4 127f 8 89* 4 
Dexamethasone 36&6 138* 9 86i 7 
Insulin 34f2 130* 13 86zt 3 
Dexamethasone + insulin 32*6 124* 9 87* 4 
’ Significantly different from control value, ~~0.01 
b Significantly different from value with dexamethasone alone, ~~0.01 
Skeletal or cardiac muscle myoblasts were grown in culture in presence or absence of either lo-’ M dexamethasone 
or 50 mu/ml insulin or both for 5 days and subsequently incubated for 48 h in presence or absence of the same com- 
pound(s) as in the growth medium to follow proteolysis and viability. Myofibrillar protease activity was determined in
myofibrils obtained after the 48 h incubation period. Results are mean values &SEM for 5 plates/group 
myoblasts was determined alone and in combina- 
tion with dexamethasone. Table 2 shows that in- 
sulin, added to the growth medium at 50 mu/ml 
daily throughout the period of culture did not af- 
fect proteolysis, myofibrillar protease activity or 
viability in skeletal muscle cells. However, insulin 
completely reversed the dexamethasone-induced 
enhancement of proteolysis and myofibrillar pro- 
tease activity in these myoblasts. A IO-fold lower 
concentrition of insulin (5 mu/ml) failed to have 
any effect on these parameters either when present 
alone or in combination with dexamethasone (not 
shown). Table 2 also shows that proteolysis and 
myofibrillar protease activity in cardiac muscle 
myoblasts were refractory to 50 mu/ml insulin, 
either when added alone or in combination with 
dexamethasone. 
4. DISCUSSION 
Proteolysis in cultured muscle cells is regulated 
by the same nutritional and hormonal factors 
which regulate proteolysis of skeletal and cardiac 
muscle cells in vivo. Administration of dex- 
amethasone increased protein degradation in 
skeletal muscle in vivo [7,9] and in vitro [lO,ll], 
while cardiac muscle was refractory to the protein 
wasting effect of glucocorticoid hormones [ 10,111. 
Serum deprivation caused an increase in cell pro- 
tein degradation in cultured skeletal and cardiac 
muscle cells [lO,l 11, and starvation of the intact 
animal enhanced protein catabolism in both tissues 
to a similar extent [8]. 
The present results indicate a correlation be- 
tween overall proteolysis and specific activity of 
the myofibrillar protease. Specifically, the alkaline 
protease of cultured muscle cells, measured by rate 
of degradation of [14C]globin by isolated myo- 
fibrils responds to dexamethasone and serum- 
deprivation by enhanced activity. The same activi- 
ty in cultured heart cells responds only to serum- 
deprivation. The analogous reaction of intra- 
cellular proteolysis in intact cells and the isolated 
myofibrillar enzyme to catabolic conditions 
strongly suggests that the myofibril-bound pro- 
tease is involved in the tissue-specific response of 
skeletal and cardiac muscles to catabolic stimuli. 
Diabetes is another condition associated with 
skeletal muscle wasting and a marked increase in 
the myofibrillar protease activity. Treatment of 
diabetic animals with insulin is known to reverse 
the enhanced degradation of skeletal muscle pro- 
teins [3,8]. We find here that the enhancement of 
proteolysis and the increase in myofibrillar pro- 
tease action induced by glucocorticoids are both 
reversed by insulin. Apparently, the myofibrillar 
241 
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protease, by virtue of its adaptive responses to 
catabolic stimuli, mediates the enhanced degrada- 
tion of muscle proteins occurring under conditions 
of muscle protein mobilization. Insulin under these 
conditions only acts on the induced but not on 
basal protein degradation and basal myofibrillar 
protease activity. 
The role of the alkaline myofibrillar protease in 
regulation of intracell~ar proteolysis in skeletal 
muscle has been recently challenged by findings 
that rat peritoneal mast cells contain high activities 
of a chymotrypsin-like alkaline protease [ 17-191, 
and that the muscle enzyme has a structural and 
immunological similarity to a chymotrypsin-like 
mast cell enzyme [16,20,21]. Since mast cells are 
removed from the culture by the selective attach- 
ment and continuous washing of the myoblasts 
[ 111, the present finding that the myofibrillar pro- 
tease is an intrinsic component of pure myoblasts 
in culture, and its responsiveness to mediators 
which induce muscle wasting and proteolysis, sup- 
ports the contention that the enzyme is not a con- 
taminant derived from mast cells. In another study 
(in preparation) the enzyme in culture was found 
to be refractory to the mast cell degranulator com- 
pound 48/80. 
The response of the protease in muscle to 
glucocorticoids is likely to involve binding of the 
hormone to cytoplasmic receptor sites [22]. 
Specific glucocorticoid receptors are demonstrable 
in skeletal muscle and in cultured myoblasts 
123,241. Presence of glucoco~icoid-s~~ific bind- 
ing activity in the cells, the effect of glucocor- 
ticoids on proteolysis and the effect of glucocor- 
ticoids on myofibrillar protease activity strongly 
suggest hat the steroid-specific receptor system in 
myoblasts is involved in the proteolytic response of 
this target tissue to glucocorticoid hormone. 
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